Circulating leptin level and growth hormone response to stimulation tests in obese and normal children

European Journal of Endocrinology

Volumn 139, Issue 6, 1998, Pages 591-597

  Coutant, Régis ^a   Lahlou, Najiba ^a   Bouvattier, Claire ^a   Bougnères, Pierre ^a,b  

^a INSERM   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LEPTIN;

ARTICLE; BODY FAT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BODY HEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; OBESITY; PROTEINS; REFERENCE VALUES; SECRETORY RATE; STIMULATION, CHEMICAL;

EID: 0032433605     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390591     Document Type: Article

References (20)

1. Bertherat J, Bluet-Pajot MT & Epelbaum J. Neuroendocrine regulation of growth hormone. European Journal of Endocrinology 1995 132 12-24.
2. Alba-Roth J. Muller OA, Schopohl J & vonWerder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. Journal of Clinical Endocrinology and Metabolism 1988 67 1186-1189.
3. Ross JL. Cassorla FG. Skerda MG, Valk IM, Loriaux DL & Cutler GB Jr. A preliminary study of the effect of oestrogen dose on growth in Turner's syndrome. New England Journal of Medicine 1983 309 1104-1106.
4. Link K, Blizzard RM, Evans WS, Kaiser DL. Parker MW & Rogol AD. The effect of androgens on pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. Journal of Clinical Endocrinology and Metabolism 1986 62 159-164.
5. Katz HP. Youlton R, Kaplan SL & Grumbach MM. Growth and growth hormone. 3. Growth and growth hormone release in children with primary hypothyroidism and thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 1969 29 346-351.
6. Stewart PM, Smith S, Seth J. Stewart SE, Cole D & Edwards CR. Normal growth hormone response to the 75 g oral glucose tolerance test measured by immunoradiometric assay. Annals of Clinical Biochemistry 1989 26 205-208.
7. Blackard WG, Hull EW & Lopez A. Effect of lipids on growth hormone secretion in humans. Journal of Clinical Investigation 1971 50 1439-1443.
8. Wehrenberg WB, Baird A & Ling N. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science 1983 221 556-558.
9. Lanzi R, Manzoni MF, Andreotti AC, Malighelti ME, Bianchi E. Sereni LP et al. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone response to GH-releasing hormone in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1997 82 2239-2243.
10. Berelowitz M. Szabo M, Frohman LA, Firestone S, Chu L & Hintz RL. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981 212 1279-1281.
11. Williams T. Berelowitz M. Joffe SN, Thorner MO. Rivier J. Vale W et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. New England Journal of Medicine 1984 311 1403-1407.
12. Loche S. Cappa M. Borrelli P. Faedda A. Crino A, Cella SG et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence with somatomedin-C inhibition. Clinical Endocrinology 1987 27 145-153.
13. Rosskampf R. Becker M & Soetadjii S. Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on the plasma levels of growth hormone and somatomedin-like immunoreactivity in obese children. European Journal of Pediatrics 1987 146 48-50.
14. Bereu BB. Sculman DI & Root AW. Obesity decreases endogenous growth hormone secretion in children with normal growth velocities. Pediatric Research 1988 23 272A.
15. Veldhuis JD, Iranmesh A. Ho KKY, Waters MJ. Johnson ML & Lizzaralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59.
16. Martha Jr PM. German KM, Blizzard RM. Rogol AD & Veldhuis JD. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. Journal of Clinical Endocrinology and Metabolism 1992 74 336-344.
17. Iranmanesh A, Lizzarralde G & Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism 1991 73 1081-1088.
18. Kelijman M & Frohman LA. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and non-obese subjects. Journal of Clinical Endocrinology and Metabolism 1988 66 489-494.
19. Cordido F, Penalva A, Dieguez C & Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after combined administration of GH-releasing hormone and GHRP-6: evidence for marked somatotroph secretory capability in obesity. Journal of Clinical Endocrinology and Metabolism 1993 76 819-823.
20. Cordido F. Casanueva FF & Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release in obesity. Journal of Clinical Endocrinology and Metabolism 1989 68 290-293.